# VRCA (Verrica Pharmaceuticals Inc.) - SEC EDGAR Financial Statements

> Verrica Pharmaceuticals Inc. reported $22.89M in revenue and a net loss of $43.32M for the trailing twelve months ended September 30, 2026 (down 51.8% year over year), with a -184.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/VRCA
- Markdown: https://convexityos.com/fundamentals/VRCA.md
- SEC CIK: 0001660334
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:52 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001660334&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $22.89M | -51.8% YoY |
| Operating Income | TTM | -$42.17M | -184.2% margin |
| Net Income | TTM | -$43.32M | -189.2% net margin |
| Diluted EPS | TTM | -$2.03 | Split-adjusted |
| Free Cash Flow | TTM | -$17.63M | -77.0% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $14.39M | Total debt: $1.67M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $35.58M | $7.57M | $5.12M | $9.03M | $12.00M | -- | -- | -- | -- |
| Cost of Revenue | -- | $2.60M | $500K | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | -- | $4.97M | $4.62M | -- | -- | -- | -- | -- | -- |
| Research & Development | $8.86M | $11.84M | $20.30M | $12.20M | $15.93M | $15.67M | $15.44M | $12.83M | $3.73M |
| Selling, General & Admin | $35.22M | $58.82M | $47.30M | $17.41M | -- | -- | -- | -- | -- |
| Total Operating Expenses | $47.76M | $73.48M | $70.88M | $30.33M | $42.91M | $40.18M | $30.08M | $21.88M | $4.46M |
| **Operating Income** | -$12.19M | -$65.92M | -$65.76M | -$21.30M | -$30.91M | -$40.18M | -$30.08M | -$21.88M | -$4.46M |
| **EBITDA** | -$12.05M | -$65.58M | -$65.23M | -$20.84M | -$30.66M | -$40.14M | -$30.02M | -$21.86M | -- |
| Interest Income | $929K | $1.42M | $2.74M | $476K | $123K | $521K | $1.88M | $1.23M | -- |
| Interest Expense | $7.74M | $9.41M | $3.96M | $2.17M | $4.29M | $3.03M | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | -- | -- | -- | -- | -- |
| **Net Income** | -$17.89M | -$76.58M | -$67.00M | -$24.49M | -$35.08M | -$42.69M | -$28.21M | -$20.65M | -$4.46M |
| Basic EPS | -$1.68 | -$14.78 | -$14.80 | -$7.20 | -$13.00 | -$17.10 | -$11.30 | -$14.10 | -$15.60 |
| **Diluted EPS** | -$1.68 | -$14.78 | -$14.80 | -$7.20 | -$13.00 | -$17.10 | -$11.30 | -$14.10 | -$15.60 |
| Basic Shares Outstanding | 10.7M | 5.2M | 4.5M | 3.4M | 2.7M | 2.5M | 2.5M | 1.5M | 285.0K |
| Diluted Shares Outstanding | 10.7M | 5.2M | 4.5M | 3.4M | 2.7M | 2.5M | 2.5M | 1.5M | 285.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $6.91M | $5.86M | $5.02M | $5.09M | $14.34M | $12.70M | $3.44M | $344K |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | $700K | $800K |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | $2.74M | -$456K |
| Research & Development | $7.58M | $6.03M | $3.86M | $2.52M | $2.21M | $1.85M | $2.28M | $1.17M |
| Selling, General & Admin | $10.36M | $10.35M | $9.99M | $8.12M | $9.40M | $8.85M | $8.85M | $9.88M |
| Total Operating Expenses | $19.08M | $18.96M | $14.74M | $12.28M | $12.72M | $11.19M | $11.57M | $11.75M |
| **Operating Income** | -$12.17M | -$13.10M | -$9.71M | -$7.19M | $1.63M | $1.51M | -$8.13M | -$11.41M |
| **EBITDA** | -$12.16M | -$13.08M | -$9.70M | -$7.18M | $1.65M | $1.55M | -$8.08M | -$11.36M |
| Interest Income | $45K | $111K | $201K | $205K | $159K | $228K | $337K | $205K |
| Interest Expense | $285K | $164K | $160K | $1.31M | $2.09M | $2.13M | $2.20M | $2.35M |
| **Net Income** | -$12.41M | -$13.15M | -$9.68M | -$8.07M | -$274K | $204K | -$9.74M | -$16.20M |
| Basic EPS | -$0.58 | -$0.62 | -$0.45 | -- | -$0.03 | $0.02 | -$1.03 | -- |
| **Diluted EPS** | -$0.58 | -$0.62 | -$0.45 | -- | -$0.03 | $0.02 | -$1.03 | -- |
| Basic Shares Outstanding | 21.3M | 21.3M | 21.3M | -- | 9.5M | 9.5M | 9.5M | -- |
| Diluted Shares Outstanding | 21.3M | 21.3M | 21.3M | -- | 9.5M | 9.5M | 9.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $30.15M | $46.33M | $69.55M | $34.27M | $15.75M | $10.69M | $9.24M | $10.27M | $8.66M |
| Short-Term Investments | -- | -- | -- | $0 | $0 | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $30.15M | $10.00M | $69.55M | $34.27M | $70.40M | $10.69M | $9.24M | $10.27M | $8.66M |
| Accounts Receivable, Net | $5.26M | $48K | $4.25M | $0 | -- | -- | -- | -- | -- |
| Inventory | $2.24M | $2.46M | $1.02M | $0 | -- | -- | -- | -- | -- |
| **Total Current Assets** | $42.54M | $51.18M | $77.53M | $39.12M | $74.33M | $67.65M | $64.98M | $91.15M | $9.08M |
| Property, Plant & Equipment, Net | $209K | $589K | $1.05M | $3.89M | $3.89M | $3.10M | $2.09M | $255K | -- |
| Other Non-Current Assets | $376K | $376K | $452K | $276K | $295K | $1.57M | $1.24M | -- | -- |
| **Total Non-Current Assets** | $4.59M | $2.96M | $4.07M | $5.61M | $5.80M | $6.50M | $3.44M | $754K | $0 |
| **Total Assets** | $47.13M | $54.13M | $81.60M | $44.72M | $80.12M | $74.15M | $68.42M | $91.91M | $9.08M |
| Accounts Payable | $2.07M | $1.90M | $2.46M | $507K | $845K | $348K | $1.19M | $922K | $153K |
| Short-Term Debt | $0 | $12.94M | $0 | $0 | $41.69M | $35.31M | -- | -- | -- |
| Deferred Revenue (Current) | $782K | $0 | -- | -- | -- | $500K | -- | -- | -- |
| Other Current Liabilities | $119K | $105K | $244K | $0 | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $16.44M | $29.01M | $17.02M | $3.46M | $46.05M | $39.48M | $3.35M | $2.48M | $616K |
| Long-Term Debt | $0 | $18.05M | $42.87M | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $5.95M | $34.98M | $44.81M | $1.23M | $1.47M | $1.69M | $58K | $0 | $0 |
| **Total Liabilities** | $22.39M | $63.99M | $61.83M | $4.69M | $47.52M | $41.17M | $3.41M | $2.48M | $616K |
| **Total Debt (incl. Leases)** | $1.63M | $33.00M | $45.51M | $1.53M | $43.41M | $37.21M | $188K | -- | -- |
| Common Stock | $2.0K | $1.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | -- |
| Retained Earnings | -$324.9M | -$307.0M | -$230.4M | -$163.5M | -$139.0M | -$103.9M | -$61.19M | -$33.08M | -$12.44M |
| Accumulated Other Comp. Income | -- | -- | -- | $0 | -$29K | $1.0K | $20K | -$17K | -- |
| **Total Stockholders' Equity** | $24.74M | -$9.86M | $19.76M | $40.03M | $32.60M | $32.99M | $65.02M | $89.43M | -$7.04M |
| Total Equity | $24.74M | -$9.86M | $19.76M | $40.03M | $32.60M | $32.99M | $65.02M | $89.43M | -$7.04M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $14.39M | $11.20M | $20.60M | $30.15M | $21.10M | $15.40M | $29.59M | $46.33M |
| **Cash & Short-Term Investments** | $14.39M | $11.20M | $20.60M | $30.15M | $21.10M | $15.40M | $10.00M | $10.00M |
| Accounts Receivable, Net | $11.24M | $10.94M | $7.72M | $5.26M | $7.05M | $9.19M | $5.61M | $48K |
| Inventory | $2.80M | $2.71M | $1.97M | $2.24M | $2.30M | $2.52M | $2.46M | $2.46M |
| **Total Current Assets** | $36.40M | $32.64M | $34.13M | $42.54M | $36.27M | $36.78M | $39.47M | $51.18M |
| Property, Plant & Equipment, Net | $167K | $177K | $191K | $209K | $225K | $315K | $537K | $589K |
| Other Non-Current Assets | $638K | $638K | $640K | $376K | $376K | $376K | $376K | $376K |
| **Total Non-Current Assets** | $3.46M | $3.38M | $4.66M | $4.59M | $4.62M | $2.33M | $2.70M | $2.96M |
| **Total Assets** | $39.86M | $36.02M | $38.79M | $47.13M | $40.90M | $39.11M | $42.18M | $54.13M |
| Accounts Payable | $1.29M | $1.60M | $2.19M | $2.07M | $1.58M | $2.32M | $1.44M | $1.90M |
| Short-Term Debt | -- | -- | -- | $0 | $12.46M | $12.67M | $12.82M | $12.94M |
| Deferred Revenue (Current) | $1.10M | $1.33M | $1.03M | $782K | $1.56M | $481K | -- | $0 |
| Other Current Liabilities | $33K | $180K | $200K | $119K | $59K | $366K | $166K | $105K |
| **Total Current Liabilities** | $21.93M | $22.44M | $16.22M | $16.44M | $28.91M | $29.22M | $29.40M | $29.01M |
| Long-Term Debt | -- | -- | -- | $0 | $9.16M | $11.90M | $14.99M | $18.05M |
| **Total Non-Current Liabilities** | $23.91M | $9.27M | $6.51M | $5.95M | $29.03M | $27.37M | $31.36M | $34.98M |
| **Total Liabilities** | $45.84M | $31.71M | $22.73M | $22.39M | $57.94M | $56.59M | $60.75M | $63.99M |
| **Total Debt (incl. Leases)** | $1.67M | $1.81M | $1.44M | $1.63M | $23.28M | $26.22M | $29.61M | $33.00M |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $9.0K | $1.0K |
| Retained Earnings | -$360.2M | -$347.7M | -$334.6M | -$324.9M | -$316.8M | -$316.6M | -$316.8M | -$307.0M |
| **Total Stockholders' Equity** | -$5.97M | $4.31M | $16.05M | $24.74M | -$17.04M | -$17.48M | -$18.58M | -$9.86M |
| Total Equity | -$5.97M | $4.31M | $16.05M | $24.74M | -$17.04M | -$17.48M | -$18.58M | -$9.86M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$17.89M | -$76.58M | -$67.00M | -$24.49M | -$35.08M | -$42.69M | -$28.21M | -$20.65M | -$4.46M |
| Depreciation & Amortization | $133K | $342K | $530K | $454K | $244K | $43K | $64K | $20K | -- |
| Stock-Based Compensation | $3.32M | $7.16M | $14.38M | $4.99M | $6.05M | $9.82M | $3.33M | $2.25M | $82K |
| Change in Receivables | -$5.21M | $4.20M | -$3.86M | $0 | -- | -- | -- | -- | -- |
| Change in Payables | $176K | -$568K | $2.20M | -$338K | $497K | -$838K | $263K | $769K | $86K |
| **Operating Cash Flow** | -$17.63M | -$60.93M | -$38.58M | -$18.65M | -$27.58M | -$30.21M | -$27.41M | -$17.87M | -$4.58M |
| Capital Expenditure | $0 | -$27K | -$362K | -$302K | -$883K | -$1.47M | -$682K | -$774K | -- |
| **Free Cash Flow** | -$17.63M | -$60.95M | -$38.94M | -$18.95M | -$28.46M | -$31.68M | -$28.09M | -$18.65M | -- |
| Purchases of Investments | -- | -- | $0 | -$4.49M | -$68.91M | -$71.74M | -$89.85M | -$79.12M | -- |
| **Investing Cash Flow** | $0 | -$19K | -$362K | $54.04M | -$998K | -$3.58M | $25.95M | -$79.89M | -- |
| Common Stock Issued | -- | -- | -- | $26.90M | $28.12M | -- | -- | -- | -- |
| **Financing Cash Flow** | $1.45M | $37.73M | $74.21M | -$16.87M | $33.65M | $35.23M | $423K | $99.38M | $12.72M |
| **Net Change in Cash** | -$16.18M | -$23.22M | $35.27M | $18.52M | $5.07M | $1.45M | -$1.03M | $1.61M | $8.14M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.41M | -$13.15M | -$9.68M | -$8.07M | -$274K | $204K | -$9.74M | -$16.20M |
| Depreciation & Amortization | $10K | $15K | $17K | $14K | $22K | $45K | $52K | $54K |
| Stock-Based Compensation | $1.91M | $1.21M | $897K | $686K | $718K | $888K | $1.03M | $756K |
| Change in Receivables | -$299K | -$3.21M | -$2.46M | $1.79M | $2.15M | -$3.59M | -$5.56M | -$201K |
| Change in Inventory | -$92K | -$738K | $262K | -- | $218K | -$59K | $0 | -- |
| Change in Payables | -$529K | -$590K | $121K | $487K | -$736K | $878K | -$453K | $931K |
| **Operating Cash Flow** | -$9.04M | -$9.28M | -$9.16M | -$4.59M | $9.69M | -$10.04M | -$12.68M | -$16.06M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$16.06M |
| **Investing Cash Flow** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $8.0K |
| **Financing Cash Flow** | $12.23M | -$126K | -$120K | $13.64M | -$3.98M | -$4.16M | -$4.06M | $39.43M |
| **Net Change in Cash** | $3.20M | -$9.40M | -$9.28M | $9.05M | $5.70M | -$14.20M | -$16.73M | $23.37M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | 65.6% | 90.2% | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -34.2% | -871.3% | -1283.4% | -235.8% | -257.6% | -- | -- | -- | -- |
| **Net Profit Margin** | -50.3% | -1012.1% | -1307.5% | -271.1% | -292.3% | -- | -- | -- | -- |
| Return on Equity (ROE) | -72.3% | -- | -339.0% | -61.2% | -107.6% | -129.4% | -43.4% | -23.1% | -- |
| Return on Assets (ROA) | -37.9% | -141.5% | -82.1% | -54.8% | -43.8% | -57.6% | -41.2% | -22.5% | -49.1% |
| Current Ratio | 2.59x | 1.76x | 4.55x | 11.31x | 1.61x | 1.71x | 19.39x | 36.80x | 14.75x |
| Quick Ratio | 2.45x | 1.68x | 4.49x | 11.31x | 1.53x | 0.27x | 2.76x | 4.15x | 14.06x |
| Debt to Equity | 0.07x | -- | 2.30x | 0.04x | 1.33x | 1.13x | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | +370.2% | +47.7% | -43.3% | -24.7% | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | -- | +7.4% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | 63.8% | 65.6% |
| **Operating Margin** | -184.2% | -93.6% | -37.1% | -34.2% | -53.2% | -263.4% | -772.4% | -871.3% |
| **Net Profit Margin** | -189.2% | -102.8% | -48.0% | -50.3% | -84.4% | -330.5% | -919.2% | -1012.1% |
| Return on Equity (ROE) | -- | -724.0% | -111.0% | -72.3% | -- | -- | -- | -- |
| Return on Assets (ROA) | -108.7% | -86.6% | -46.0% | -37.9% | -63.6% | -124.3% | -156.5% | -141.5% |
| Current Ratio | 1.66x | 1.45x | 2.10x | 2.59x | 1.25x | 1.26x | 1.34x | 1.76x |
| Quick Ratio | 1.53x | 1.33x | 1.98x | 2.45x | 1.18x | 1.17x | 1.26x | 1.68x |
| Debt to Equity | -- | 0.42x | 0.09x | 0.07x | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -51.8% | -53.8% | +46.1% | +1380.2% | -- | +145.4% | -10.1% | -82.7% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -12.4% | -- |
| Operating Income Growth (YoY) | -847.8% | -967.4% | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -6547.5% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -3200.0% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -193.3% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
